(reported by the Company)
No items found
Nucleotrace has developed the first product-integrated supply chain monitoring and anti-counterfeiting technology for consumable products. Information such as the batch number, expiry date and manufacturing facility are encoded into fragments of DNA which are incorporated into the product as a non-toxic molecular fingerprint. Nucleotrace technology has the capacity to significantly reduce drug counterfeiting which is responsible for one million deaths and costs the pharmaceuticals industry $100 billion each year.
|Category:||Defence, Health & biotech|
|ASX Listing Code (if applicable):|
|Year of Commencement:|
Inspire9, 41 Stewart St.
|Current Period Rank:|
Won Tech23's Innovation Excellence Award and Addisons Award
Accepted into Startmate accelerator (includes $75k funding)
NOTE: Company News, Milestones and Funding are as collected by Techboard as part of our Monthly Startup Ranking
|Type of capital raise:|